Leap Therapeutics
LPTX
LPTX
57 hedge funds and large institutions have $55.3M invested in Leap Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11.73% more ownership
Funds ownership: 38.46% → 50.19% (+12%)
70% less call options, than puts
Call options by funds: $43K | Put options by funds: $142K
Holders
57
Holding in Top 10
1
Calls
$43K
Puts
$142K
Top Buyers
| 1 | +$4.03M | |
| 2 | +$592K | |
| 3 | +$578K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$465K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$460K |
Top Sellers
| 1 | -$7.93M | |
| 2 | -$1.07M | |
| 3 | -$319K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$310K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$173K |